October 7, 2008, 10:38 PM CT

Wheezing and asthma in young children

The diagnosis of asthma in a young child may well be more challenging to pediatricians than previously appreciated, as per a review of research and clinical experience literature by Howard Eigen, M.D., of the Indiana University School of Medicine and Riley Hospital for Children appearing in the October 2008 issue of Clinical Pediatrics

"Wheezing can be serious," said Dr. Eigen, the Billie Lou Wood Professor of Pediatrics at the IU School of Medicine and director of pediatric pulmonology and critical care at Riley Hospital. "A comprehensive review of clinical practice and peer evaluated studies show that the difficulty of accurate diagnosis is often underestimated by pediatricians who may link it to a passing cold or other non-serious condition rather than relating it to asthma, a chronic and potentially serious disease".

Dr. Eigen noted in his study that in early childhood asthma is often under recognized and under diagnosed because the symptoms can vary widely and are similar to other common childhood illnesses, including a non-specific cough, flu and bronchitis. Establishing a diagnosis of asthma in young wheezing children also can be challenging for the doctor because the type, severity and frequency of asthma symptoms vary widely among children and, sometimes even with an individual child......... Posted by: JoAnn      Read more         Source

September 22, 2008, 10:38 PM CT

Pollution, everyday allergens, may be sources of laryngitis

Everyday exposure to environmental tobacco smoke, allergens, and air pollution may be the root of chronic cases of laryngitis, says new research presented at the 2008 American Academy of Otolaryngology Head and Neck Surgery Foundation (AAO-HNSF) Annual Meeting & OTO EXPO in Chicago, IL.

Laryngitis symptoms include hoarseness of the voice, cough, and chronic clearing of the throat. Scientists and physicians generally attribute laryngitis to a viral infection and overuse of the voice. Other factors, including consistent exposure to second-hand smoke, have also been cited as a trigger.

Scientists have now found through animal models that exposure to different environmental pollutants, including dust mites and everyday air pollution, can cause what they term as "environmental laryngitis".

The findings are significant, given recent reports on diminishing air quality and increased unhealthy levels of ozone and particle pollution, particularly in countries like China, which could lead to more cases of laryngitis and chronic laryngitis......... Posted by: JoAnn      Read more         Source

July 10, 2008, 8:33 PM CT

Link shown between thunderstorms and asthma attacks

In the first in-depth study of its kind ever done in the Southeastern United States, scientists at the University of Georgia and Emory University have discovered a link between thunderstorms and asthma attacks in the metro Atlanta area that could have a "significant public health impact".

While a relationship between thunderstorms and increased hospital visits for asthma attacks has been known and studied worldwide for years, this is the first time a team of climatologists and epidemiologists has ever conducted a detailed study of the phenomenon in the American South.

The team, studying a database consisting of more than 10 million emergency room visits in some 41 hospitals in a 20-county area in and around Atlanta for the period between 1993 and 2004, found a three percent higher occurence rate of visits for asthma attacks on days following thunderstorms.

"While a three percent increase in risk may seem modest, asthma is quite prevalent in Atlanta, and a modest relative increase could have a significant public health impact for a region with more than five million people," said Andrew Grundstein, a climatologist in the department of geography at UGA and lead author on the research. Grundstein went on to say that "three percent is likely conservative because of limitations in this study"......... Posted by: JoAnn      Read more         Source

June 18, 2008, 9:08 PM CT

Caesarean sections associated with risk of asthma

Babies born by Caesarean section have a 50 % increased risk of developing asthma in comparison to babies born naturally. Emergency Caesarean sections increase the risk even further. This is shown in a new study based on data from 1.7 million births registered at the Medical Birth Registry at the Norwegian Institute of Public Health.

The goal of the study was to investigate the possible link between being born by Caesarean section and later development of asthma.

Summarised results from the study:.

• In comparison to children born in the natural way (i.e. spontaneously and vaginally), children born by Caesarean section had an approximately 50 % increased risk of developing asthma.
• Children born vaginally, but with assistance from vacuum or forceps, had a 20 % increased risk of asthma.
• For children born between 1988 and 1998, planned Caesarean section was linked to an approximately 40 % increased risk of asthma while emergency Caesarean section was linked to a 60 % increased risk.

.

Why do Caesarean sections give an increased risk of asthma?

- We found a moderately strong association between birth by Caesarean section and asthma in childhood, says doctor and research fellow Mette Christophersen Tollånes, who works for both the Norwegian Institute of Public Health and the Department of Public Health and Primary Health Care at the University of Bergen, Norway......... Posted by: Emily      Read more         Source

June 4, 2008, 11:06 PM CT

Symbicort for treatment of asthma in children as young as 6

AstraZeneca today announced that it submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for approval of a new indication for SYMBICORT® (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol for the long-term maintenance therapy of asthma in pediatric patients ages 6 to 11 years old. SYMBICORT is currently approved for the long-term maintenance therapy of asthma in patients 12 years and older.

"Millions of children in the U.S. are affected by asthma1," said lead investigator Jeffrey Leflein, MD, Allergy & Immunology Associates of Ann Arbor, Michigan. "SYMBICORT could potentially offer another therapy option for the long-term maintenance of asthma in young children whose condition is not adequately controlled with inhaled corticosteroids alone".

The submission package is based on a robust clinical development program consisting of five active or placebo-controlled Phase III trials assessing the efficacy and safety of SYMBICORT pressurized metered-dose inhaler (pMDI) that included 1,446 children ages 6 to 11 years old with asthma.2 The proposed starting dose for children (80/9 mcg twice-daily) was studied in one pivotal randomized, double-blind, active-controlled, 12-week study that reviewed 256 children ages 6 to 11 years old with mild-to-moderate persistent asthma previously treated with inhaled corticosteroid treatment.3 In this study, SYMBICORT was in comparison to budesonide pMDI and formoterol dry powder inhaler.3 A second study evaluating this dose included 351 subjects ages 6 to 11 years old.4 Results from both studies demonstrated that SYMBICORT 80/9 mcg twice daily had a similar safety profile to one of the mono-components, budesonide;4,5 likewise, results from the first study also observed that SYMBICORT 80/9 mcg twice daily had a similar safety profile to its other mono-component, formoterol.5 The most common adverse events reported were headache, pyrexia, upper respiratory tract infection, nasopharyngitis, and pharyngolaryngeal pain.2 ......... Posted by: JoAnn      Read more         Source

June 1, 2008, 10:49 PM CT

Cold Medication Use in Young Children

significant number of adverse effects and several deaths, leading the FDA to recommend against their use for children less than two years old. Despite these concerns about safety and efficacy, there has been little research on patterns of cough and cold medicine use in very young children. Now, a new study from the Emergency Medicine Network (www.emnet-usa.org) led by Katherine O'Donnell, M.D. of Children's Hospital Boston reveals important new statistics about medicine use in children under the age of two.

As per the study, 1-in-3 children under the age of two with bronchiolitis (a lower respiratory tract infection linked to runny nose, cough, wheezing and/or difficulty breathing) had received over-the-counter cough and cold medicines in the week previous to visiting an emergency department.

This study identifies rates and predictors of cough and cold medicine use previous to the manufacturer recall of and FDA recommendations against use of these medications in children younger than two years of age.

"After the recall and labeling changes, it will be important to monitor for potential ongoing use of these medicines in young children and observe if parents or physicians are turning to other therapies in place of these medications," says O'Donnell......... Posted by: JoAnn      Read more         Source

May 20, 2008, 9:39 PM CT

SYMBICORT in children with persistent asthma

A new 12-week study2examined safety and efficacy measures of the maintenance combination asthma treatment, SYMBICORT (budesonide/formoterol fumarate dehydrate) Inhalation Aerosol,2 in treating mild to moderate persistent asthma in children ages 6 to 15 years old2 who were previously treated with an inhaled corticosteroid (ICS).2 Of note, the study included efficacy assessments of nighttime symptoms, nighttime rescue medicine use and rescue medication-free days in patients taking SYMBICORT in comparison to those taking formoterol dry powder inhaler (DPI) or budesonide pressurized metered-dose inhaler (pMDI). Results were presented today at the International Conference of the American Thoracic Society held in Toronto, Canada, May 16-21, 2008.

Children with asthma, who are not adequately controlled by ICS treatment, may have their sleep affected by asthma symptoms,6 said Kathy Lampl, MD, Director, Clinical Research, AstraZeneca. Combination treatment with inhaled ICS and LABA is one of the recommended regimens for children who have moderate to severe persistent asthma or are not controlled with ICS treatment alone, as per the NIH Guidelines. 7.

AstraZeneca (NYSE:AZN) anticipates filing a supplemental new drug application with the Food and Drug Administration for the pediatric indication of SYMBICORT in the first half of 2008......... Posted by: JoAnn      Read more         Source

May 18, 2008, 9:03 PM CT

Personalized therapy for asthma and COPD

Scientists at Washington University School of Medicine in St. Louis have defined a new type of immune response that is activated in patients with severe asthma and COPD (chronic obstructive pulmonary disease). Their discovery could dramatically improve diagnosis and therapy of patients with chronic inflammatory lung disease.

"We've cracked the first part of the molecular code that links a viral infection to the later development of chronic inflammatory diseases like asthma and COPD," says senior author Michael Holtzman, M.D., the Selma and Herman Seldin Professor of Medicine, director of the Division of Pulmonary and Critical Care Medicine and a pulmonary specialist at Barnes-Jewish Hospital. "With this information, we can more precisely diagnose and monitor these types of diseases and then better target our therapy to specific abnormalities. That's a big step forward from simply monitoring breathing status".

The findings, published online May 18, 2008, in Nature Medicine, promise a way to determine whether a patient's asthma or COPD is the result of a chronic immune response that can be turned on by a respiratory viral infection. Guided by these new findings, this type of immune response could be detected by monitoring specific types of inflammatory cells or molecules in the lung or potentially in the bloodstream, giving physicians a more precise approach to diagnosis and therapy of lung disease......... Posted by: JoAnn      Read more         Source

May 3, 2008, 7:45 PM CT

1 in 10 children using cough, cold medications

Scientists from Boston Universitys Slone Epidemiology Center have observed that approximately one in ten U.S. children uses one or more cough and cold medications during a given week. These findings will be presented today at the 2008 Pediatric Academic Societies & Asian Society for Pediatric Research Joint Meeting in Honolulu, Hawaii.

Pediatric cough and cold medications are widely marketed in the U.S. but surprisingly little is known about just how often they are used in children. This information is particularly important in light of recent revelations that cough and cold medications are responsible for serious adverse events and even deaths among children.

To define the frequency and patterns of use, the scientists analyzed data between 1999 and 2006 from the Slone Survey, a national telephone survey of medicine use in a representative sample of the U.S. population. The authors considered all oral medicines that are approved by the FDA to treat childrens coughs and colds.

The scientists observed that in a given week, at least one cough and cold medicine was used by 10.1 percent of U.S. children. In terms of active ingredients contained in these medications, exposure was highest to decongestants and antihistamines (6.3 percent each), followed by anti-cough ingredients (4.1 percent) and expectorants (1.5 percent)......... Posted by: JoAnn      Read more         Source

April 9, 2008, 10:12 PM CT

Traffic exhaust can cause asthma

Children exposed to high levels of air pollution during their first year of life run a greater risk of developing asthma, pollen allergies, and impaired respiratory function. However, genetic factors are also at play. These are the results of a new study conducted under the BAMSE project.

The BAMSE project has monitored 4,000 children in Stockholm county from birth in order to assess whether exposure to traffic pollution during their first year of life affects the risk of developing asthma and allergies. Levels of traffic exhaust were measured at the site of the home. The results show that the children who were exposed to high concentrations of pollutants ran a 60 per cent higher risk of suffering of persistent asthma symptoms. Respiratory function was also adversely affected, and the children were much more likely to be allergic to airborne allergens, especially pollen.

Studies were also made of how the risk of developing air pollution-related allergies is influenced by genetic factors. It was observed that children carrying a variant of GSTP1 (glutathione S-transferase P1) gene, which is crucial to the bodys ability to take care of air pollutants (the antioxidative system), run a greater risk of developing an allergy associated with traffic-related air pollution. As per new analyses, variants of another asthma gene, TNF (tumour necrosis factor), also affect sensitivity to air pollution. Children with a particular combination of GSTP1 and TNF variants run a considerably higher risk of developing allergies......... Posted by: JoAnn      Read more         Source

April 9, 2008, 8:45 PM CT

First do no harm?

One month of tough breathing may help asthma sufferers breathe easier in the long run, as per research from one University of Houston professor.

In a move that challenges one of the most basic tenets of the Hippocratic Oath first do no harm Richard Bond, associate professor of pharmacology at UH, is relying on a long-standing medical taboo to treat asthma. Eventhough counterintuitive, Bonds studies are reminiscent of hair-of-the-dog folk wisdom to treat like with like, in this case using beta blockers (or antagonists) instead of stimulants (or agonists) in asthmatics.

Coining the term paradoxical pharmacology treating patients with medicine that initially worsens their symptoms before eventually improving their overall health Bond first applied this hypothesis in studies with mice and then moved on to two clinical trials with humans. Currently in the second clinical trial, the part of this research analyzing mice was recently reported in the American Journal of Respiratory Cell and Molecular Biology, which cited the relevance of Bonds work as possibly leading to a paradigm shift in the therapy of asthma. The results of the first human trial were also recently published in Pulmonary Pharmacology and Therapeutics.

Acute asthma attacks have traditionally been treated with inhaler-type stimulant drugs that open constricted airways. Giving beta blockers to asthmatics has long been believed to be contraindicated, because their acute use may cause increased airway resistance. While the use of beta-stimulants is known to provide temporary relief, their effectiveness declines over time......... Posted by: JoAnn      Read more         Source

April 7, 2008, 10:45 PM CT

Asthma and Smoker's Lung

Dry airways may not only play a central role in the development of the in-herited lung disease cystic fibrosis, but also in much more common ac-quired chronic lung diseases such as asthma and smoker's lung, the ciga-rette smoke-induced chronic obstructive pulmonary disease (COPD). This is the conclusion reached by researchers at Heidelberg University Hospital under the direction of Assistant Professor Dr. Marcus Mall from the Department of Pediatrics at Heidelberg University Hospital and Professor Dr. Richard Boucher of the University of North Carolina at Chapel Hill. In ani-mal studies, they observed that insufficient hydration of the airway surfaces leads to pathologies typical of chronic obstructive lung diseases in humans.

Thus, these findings point to a new approach for the therapy of these diseases, which are listed by the World Health Organization WHO as the fourth leading cause of death worldwide. There are currently no causal therapies available for treating these diseases; only the symptoms such as shortness of breath and oxygen deficiency can be treated. The results of the study have now been reported in the "American Journal of Respira-tory and Critical Care Medicine".

Cystic fibrosis gene causes airways to dry out and thickens mucus.

In the hereditary disease cystic fibrosis, which affects about 8,000 people in Gera number of (about 80,000 people in the Western world), a defective gene causes a change in the transport of salt and water across the mucosal sur-faces in the lungs, the intestine and other organs, and thus produce a change in the composition of the secretions......... Posted by: JoAnn      Read more         Source

March 9, 2008, 5:52 PM CT

Allergic Response Tied to Lipid Molecules

A team of Penn State University scientists is the first to demonstrate that lipid molecules in cell membranes participate in mammals' reactions to allergens in a living cell. The finding will help researchers better understand how allergy symptoms are triggered, and could contribute to the creation of improved drugs to treat them. The work would be published in the 14 recent issue of the Journal of Biological Chemistry.

The team studied clusters of cholesterol-rich lipid molecules that they believe serve as platforms for the receptors that receive antibodies, the proteins that protect the body from allergens. In this case, the team examined IgE antibodies, which upon binding to their receptors initiate a cell's release of histamine--the substance that causes the unpleasant, but beneficial, mucous production, congestion, and itchiness linked to allergies. "This research is basically the molecular foundation for why a number of people sneeze in the spring," said Ahmed Heikal, an associate professor in the Department of Bioengineering and a leader of the project.

While the idea that lipid clusters--also known as lipid domains--are involved in the allergic response is not new, the Penn State team is the first to document this connection in a living cell under physiological conditions. "No one has observed the domains in action because they are too small and too transient--held together by very weak molecular interactions--to be viewed with a light microscope," said Erin Sheets, a Penn State assistant professor of chemistry who also is a leader of the project. "To overcome this challenge," added Heikal, "we used a combination of imaging and spectroscopy techniques that we are in the process of developing in our laboratories......... Posted by: JoAnn      Read more         Source

March 2, 2008, 8:57 PM CT

Increased allergen levels in homes linked to asthma

Results from a new national survey demonstrate that elevated allergen levels in the home are linked to asthma symptoms in allergic individuals. The study suggests that asthmatics that have allergies may alleviate symptoms by reducing allergen exposures inside their homes. The work was carried out by scientists at the National Institute of Environmental Health Sciences (NIEHS), the University of Iowa, Rho Inc., and the Constella Group. The teams findings may help millions of Americans who suffer from asthma.

Indoor allergen exposures are of great importance in relation to asthma because most people spend a majority of their time indoors, particularly at home, said Darryl Zeldin, M.D., a Principal Investigator in the Laboratory of Respiratory Biology at NIEHS and senior author on the paper.

Asthma is one of the most common chronic ailments in the United States, affecting more than 22 million people. Asthma has been shown to be triggered by a wide range of substances called allergens.

The findings, published online and available in the recent issue of the Journal of Allergy & Clinical Immunology, show that exposure to multiple indoor allergens was common in U.S. households with 52 percent having at least six detectable allergens and 46 percent having three or more allergens at increased levels. The indoor allergens studied included those from dog, cat, mouse, cockroach, dust mite, and the fungus Alternaria......... Posted by: JoAnn      Read more         Source

January 29, 2008, 9:26 PM CT

New Treatment Target for Asthma

An enzyme released by mast cells in the lungs appears to play a key role in the tightening of airways that is a hallmark of asthma - pointing to a potential new target for therapy against the illness.

Reporting in the online edition of Proceedings of the National Academy of Sciences, a team at Weill Cornell Medical College explains that during an immune response, mast cells release the enzyme - called renin - which in turn produces angiotensin, a potent constrictor of the smooth muscle that lines airways.

Mast cells are normally present in small numbers in all organs, and are best known for their role in allergy, shock, wound healing and defense against pathogens.

"Back in 2005, our team was the first to discover that mast cells in the heart released renin locally, which elicited heart arrhythmias by triggering angiotensin production within the heart," explained co-senior author Dr. Roberto Levi, professor of pharmacology at Weill Cornell Medical College.

"Now, we've expanded those findings to the lungs, where similar mechanisms appear to work locally to help trigger constriction in the airway," he says.

Renin is no stranger to medical research - for decades, doctors have known that the enzyme is produced by the kidney in relatively large quantities for systemic use throughout the body. But the Weill Cornell team was the first to discover that mast cells also produced their own "local" supply of the enzyme, at a variety of body sites......... Posted by: JoAnn      Read more         Source

January 17, 2008, 8:40 PM CT

opening door to 'personalized' asthma therapy

In the last few years, personalized medicine using genetic or other molecular biology-based diagnostic tests to customize therapy for a particular patient has emerged as a powerful new tool for health care.

Therapy guided by genetic testing has proven highly successful in treating some types of leukemia and breast and lung cancer. Similar personalized therapies are on the horizon for other types of cancer, as well as diabetes, heart disease and other deadly disorders.

Now, University of Texas Medical Branch at Galveston (UTMB) scientists and their colleagues elsewhere have taken the first steps toward bringing the methods of personalized medicine to asthma.

Applying state-of-the-art protein screening techniques to samples taken from 84 asthmatic volunteers, theyve made the first identification of different subtypes of asthma based on distinct protein profiles, unique combinations of 10 or more proteins with which they are associated.

One of these profiles corresponds to a variety of severe, therapy-resistant asthma that, while rare, is responsible for 40 to 50 percent of the total health care costs linked to the disease.

We know that in asthma some people respond to very specific types of therapies and others dont, said Dr. Allan Brasier, director of UTMBs Sealy Center for Molecular Medicine and a senior author of a paper on the study appearing in the just-published recent issue of the Journal of Allergy and Clinical Immunology (online at http://journals.elsevierhealth.com/periodicals/ymai). Being able to discover different asthma subtypes should allow us to tailor our therapys to increase the odds of a positive response, Brasier added......... Posted by: JoAnn      Read more         Source

January 14, 2008, 5:18 PM CT

How allergic reactions are triggered

In demonstrating that a group of calcium ion channels play a crucial role in triggering inflammatory responses, scientists at Beth Israel Deaconess Medical Center (BIDMC) have not only solved a longstanding molecular mystery regarding the onset of asthma and allergy symptoms, but have also provided a fundamental discovery regarding the functioning of mast cells. Their findings are reported in the January 2008 issue of Nature Immunology.

A group of immune cells found in tissues throughout the body, mast cells were once exclusively known for their role in allergic reactions, as per the studys lead author Monika Vig, PhD, an investigator in the Department of Pathology at BIDMC and Instructor of Medicine at Harvard Medical School. Mast cells store inflammatory cytokines and compounds [including histamine and heparin] in sacs called granules, she explains. When the mast cells encounter an allergen pollen, for example they degranuate, releasing their contents and triggering allergic reactions.

But, she adds, in recent years, researchers have uncovered numerous other roles for mast cells, suggesting they are key to many biological processes and are involved in diseases ranging from multiple sclerosis and rheumatoid arthritis to cancer and atherosclerosis.

In order for mast cells to function, they require a biological signal specifically, calcium. Calcium moves in and out of the cells by way of ion channels known as CRAC (calcium-release-activated calcium) currents. Last year, several research groups, including Vigs, identified CRACM1 as being the exact gene that was encoding for this calcium channel......... Posted by: JoAnn      Read more         Source

January 10, 2008, 10:30 PM CT

Challenge previous findings regarding asthma treatment

A new study published recently in The Lancet reveals that one of the most usually used asthma medicines -- long-acting beta-agonists -- may not be linked to adverse events in people based on their genotype (gene variation), as prior studies had shown.

The study analyzed the effects of long-acting beta-agonist treatment, used in combination with inhaled corticosteroids, in asthmatics who have a specific beta-2 adrenergic receptor (ADRB2) genotype.

Investigators analyzed data from two clinical trials performed by AstraZeneca Pharmaceuticals LP. In each trial, patients were randomized to receive one of two different long-acting beta-agonists. In the case of each of the therapies, asthma symptoms and control improved, but no differences were observed based on the ADRB2 genotype.

These results are extremely important because prior studies on short-acting beta-agonists showed evidence for an adverse genotypic effect, said Eugene R. Bleecker, M.D., Thomas H. Davis Professor of Medicine, co-director of Center for Human Genomics at Wake Forest Baptist, and lead-investigator for the study. Smaller studies on long-acting beta-agonists have produced conflicting results.

Current guidelines recommend the use of combination treatment, with long-acting beta-agonists and inhaled corticosteroids, to control moderate to severe persistent asthma......... Posted by: JoAnn      Read more         Source

January 2, 2008, 8:31 PM CT

Protein a possible key to allergy and asthma control

Activating a protein found on some immune cells seems to halt the cells typical job of spewing out substances that launch allergic reactions, a study by Johns Hopkins scientists suggests. The findings could eventually lead to new therapys for allergic reactions ranging from annoying bouts of hay fever to deadly asthma attacks.

Prior studies by Bruce Bochner and colleagues at the Johns Hopkins Asthma and Allergy Center had zeroed in on the protein, Siglec-8, as an important player in allergic reactions. This protein is found on the surfaces of some types of immune cells, namely eosinophils, basophils and mast cells, which have diverse but cooperative roles in normal immune function and allergic diseases. Eosinophils directly combat foreign invaders, such as parasites. Basophils and mast cells store and release substances such as histamine, prostaglandins and cytokines, which signal other immune system cells to ready for battle.

When functioning correctly, these cells are a valuable aid to keeping the body healthy and infection-free. However, in allergic reactions and asthma attacks, the cells unleash an overwhelming response that typically harms the body more than it helps.

The scientists found in prior studies that when they activated Siglec-8 on the surface of eosinophils, the cells promptly died. Expecting the same suicidal response in mast cells, the researchers tested their theory in a new study on human mast cells and mast-cell-containing tissues......... Posted by: JoAnn      Read more         Source

November 7, 2007, 6:55 PM CT

Viral Infections Andt Asthma In Young Children

Babies who get severe respiratory viral infections are much more likely to suffer from asthma as they get older. Now scientists at Washington University School of Medicine in St. Louis have pinpointed a key step in the development of asthma in mice after a severe respiratory infection. They suggest that medications designed to interfere with this mechanism could potentially prevent a number of cases of childhood asthma.

"A severe respiratory infection in infancy greatly increases the risk of developing asthma," says the study's lead author Mitchell Grayson, M.D., assistant professor of medicine in the Division of Allergy and Immunology. "Less than one in 30 people who don't suffer a severe respiratory infection as a baby develop asthma, but of those who do get these infections, one in five goes on to have asthma".

Grayson and his colleagues published their research in the Oct. 29, 2007, issue of the Journal of Experimental Medicine. They observed that mice that developed asthma-like symptoms after a severe respiratory viral infection had an unusual immune reaction. During the infection, the mice produced antibodies and immune signals similar to those produced during an allergic response, instead of those typically made in response to infection. That started a chain reaction that led to asthma. The scientists propose that a similar reaction occurs in some people who suffer severe respiratory viral infections......... Posted by: JoAnn      Read more         Source

November 7, 2007, 5:06 AM CT

Link between asthma and depressive disorders

Young people with asthma are about twice as likely to suffer from depressive and anxiety disorders than are children without asthma, as per a research studyby a research team in Seattle. Prior research had suggested a possible link in young people between asthma and some mental health problems, such as panic disorder, but this study is the first showing such a strong correlation between the respiratory condition and depressive and anxiety disorders. The findings are reported in the recent issue of the Journal of Adolescent Health.

The study was conducted by scientists at the University of Washington School of Medicine, Group Health Cooperative, and Seattle Children's Hospital Research Institute. The scientists interviewed more than 1,300 youths, ages 11 to 17, who were enrolled in the Group Health Cooperative health maintenance organization. Of the participants, 781 had been diagnosed with or treated for asthma, and the rest were randomly selected youths with no history of asthma.

About 16 percent of the young people with asthma had depressive or anxiety disorders, the scientists found, in comparison to about 9 percent of youth without asthma. When controlling for other possible variables, youth with asthma were about 1.9 times as likely to have such depressive or anxiety disorders......... Posted by: JoAnn      Read more         Source

October 16, 2007, 7:44 PM CT

Farm kids have lower risk of asthma

Farm children appear to have a lower risk of asthma than their urban counterparts or even those living in a non-agricultural rural environment, as per a University of Alberta study.

Analysis of two surveys involving 13,524 asthmafree children aged less than 12 years in the ongoing Canadian National Longitudinal Survey of Children and Youth (NLSCY) showed that children living in a farming environment had a lower risk of developing asthma than their counterparts who resided in either non-farming rural environments, such as residential acreages and rural towns, or an urban environment.

The two-year cumulative occurence rate of asthma was only 2.3 per cent in farm children, in comparison to 5.3 per cent for other rural and 5.7 per cent for urban children.

The study was published recently in the journal Respirology.

Farm children of ages one to five years also showed a stronger protective effect against asthma than those aged six to 11 years, possibly due to earlier exposure to the farm environment, said William Midodzi, lead author on the study and a PhD candidate in the Department of Public Health Sciences in the University of Alberta School of Public Health in Edmonton, Canada.

As well, youngsters with parental history of asthma living in farming environments had a reduced risk of asthma in comparison to children living in rural non-farm environments, whereas children with parental history of asthma living in urban areas had a higher risk when compared with children living in rural non-farm environments......... Posted by: JoAnn      Read more         Source

September 27, 2007, 9:51 PM CT

Study links asthma to allergies

Scientists at the National Institutes of Health (NIH) have observed that more than 50 percent of the current asthma cases in the country can be attributed to allergies, with approximately 30 percent of those cases attributed to cat allergy.

It has long been debated whether people who develop asthma have a genetic propensity to develop allergies, or atopy, said Darryl C. Zeldin, M.D., a senior investigator at the National Institute of Environmental Health Sciences (NIEHS). This new research shows that 56.3 percent of asthma cases are attributed to atopy. Atopy is a condition that results from gene-environment interactions and can be measured by a positive skin test to allergens (or allergy causing substances in the environment).

The study, available online today in the Journal of Allergy and Clinical Immunology, was conducted by scientists at the National Institute of Environmental Health Sciences (NIEHS) and the National Institute of Allergy and Infectious Diseases, both parts of the NIH. The data come from the Third National Health and Nutrition Examination Survey (NHANES III), a nationally representative sample of the population of the United States.

Sensitization to cat appears to be a strong risk factor for asthma in this study, said Zeldin. Zeldin and his co-authors, however, point out that some research shows that exposure to cats, especially early in life, may be a protective factor. We are not advocating parents get rid of pets, but if you suspect that you or your child might have cat allergies or get asthmatic-like symptoms, you should consult with a doctor about the best course of action for your family, added Zeldin......... Posted by: JoAnn      Read more         Source

September 20, 2007, 11:59 PM CT

Improving standard of cows' milk allergy care

New guidelines on the diagnosis and management of cows milk allergy (CMA), published recently in the Archives of Disease in Childhood, are set to improve the standard of care of infants with CMA, the most common food allergy in children.1 The Guidelines for the Diagnosis and Management of Cows Milk Protein Allergy recommend only extensively hydrolysed (eHF) and amino acid-based formulas (AAF), and the Taskforces recommendations warn against the risks of soy and other mammalian milks, such as sheep and goat, in CMA management.

Drawn up by the independent international Taskforce of allergy experts Act Against Allergy, and supported by an educational grant from SHS International, a leader in the field of specialised clinical nutrition, the guidelines offer clear recommendations on how to diagnose and manage CMA as well as two algorithms one for breast-fed infants and one for formula-fed infants addressing all levels of disease severity.

These are the first practical guidelines on CMA diagnosis and management and are specifically aimed at primary care physicians and general paediatricians, says Professor Yvan Vandenplas, Paediatric Gastroenterologist at Vrije Universiteit Brussel, Brussels, Belgium and Chair of the Act Against Allergy Taskforce. Our recommendations will assist in establishing CMA diagnosis and level of severity, offering clear guidance on the recommended management at each stage, whilst debunking some of the misconceptions over the value of soy and other alternative milk sources in CMA......... Posted by: JoAnn      Read more         Source